CALR and neoplasm: Consistent with the above findings, we have previously shown that the inhibitory action of iTSC-derived tumor-suppressive CM and tumor-suppressive proteins such as Calreticulin, Moesin, etc., is selective to tumor cells, and their inhibitory actions in MTT-based viability are stronger in tumor cells than non-tumor cells.